Living Cell Technologies Limited (LVCLF)

USD 0.01

(0.0%)

Market Cap (In USD)

8.63 Million

Revenue (In USD)

125.2 Thousand

Net Income (In USD)

-2.09 Million

Avg. Volume

3493.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.0E-4-0.01028
PE
-
EPS
-
Beta Value
0.722
ISIN
AU0000296022
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. David Richard Hainsworth
Employee Count
-
Website
https://www.lctglobal.com
Ipo Date
2010-06-01
Details
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.